30-Jun-2026 15:22:55
JAGSONPAL PHARMACEUTICALS : DISCLOSURE UNDER REGULATION 31(4) OF SEBI
• Jagsonpal Pharmaceuticals Limited is hereby enclosing the annual disclosures of its promoters under regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the year ended on March 31, 2026. • Infinity Holdings also declared that they have not made any encumbrance of shares, directly or indirectly, during the financial year ended March 31, 2026. • Rajpal Singh Kochhar and Aresko Progressive Private Limited, the promoters, declared that the members of the promoter and promoter group have not created any encumbrance over the shares of the Company, directly or indirectly, as on March 31, 2026. Impact: Neutral (Procedural filing regarding promoter share encumbrance disclosures)
Jagsonpal Pharmaceuticals Limited
Open attachment